Literature DB >> 24136849

Draft Genome Sequences of Burkholderia cenocepacia ET12 Lineage Strains K56-2 and BC7.

John J Varga1, Liliana Losada, Adrian M Zelazny, Maria Kim, Jamison McCorrison, Lauren Brinkac, Elizabeth P Sampaio, David E Greenberg, Indresh Singh, Cheryl Heiner, Meredith Ashby, William C Nierman, Steven M Holland, Joanna B Goldberg.   

Abstract

The Burkholderia cepacia complex (BCC) is a group of closely related bacteria that are responsible for respiratory infections in immunocompromised humans, most notably those with cystic fibrosis (CF). We report the genome sequences for Burkholderia cenocepacia ET12 lineage CF isolates K56-2 and BC7.

Entities:  

Year:  2013        PMID: 24136849      PMCID: PMC3798455          DOI: 10.1128/genomeA.00841-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The Burkholderia cepacia complex (BCC) consists of 17 genetically related but phenotypically distinct betaproteobacterial species. BCC species can be found in a variety of niches and are capable of infecting numerous hosts. The most well-known member of the BCC is Burkholderia cenocepacia, a pathogen of onions and immunocompromised humans (1). We report the genome sequences of B. cenocepacia strains BC7 (2) and K56-2 (3), members of the highly transmissible genomovar III ET12 lineage (4, 5). While a genome sequence exists for the ET12 lineage B. cenocepacia strain J2315 (6), BC7 was isolated from a patient with “cepacia syndrome” and K56-2 is less antibiotic resistant, making it more amenable to genetic manipulation. Genomic DNA was prepared with the DNeasy blood and tissue kit (Qiagen), according to the manufacturer’s instructions. A combination of the Roche 454 GS-FLX Titanium 8-kb mate-pair libraries (~12× coverage) and 100-bp Illumina fragment reads (50× coverage) were used for sequence determinations. All reads were used to generate hybrid assemblies with Celera Assembler version 7.0 (CA7.0) (7). Almost all of the intrascaffold breaks in these assemblies were estimated at <20 bases, suggesting that they are ambiguities likely resulting from the high content of short tandem repeats in the G+C-rich regions of the genome. Thus, we sought additional PacBio reads to obtain a better consensus of the K56-2 genome; short- and long-length PacBio reads (<2,000 and >2,000, respectively) were used to generate highly accurate, long, preassembled reads using the HGAP algorithm (Pacific Biosciences), which were combined with 454 reads and input into the CA7.0. K56-2 assembled into 14 scaffolds containing 19 contigs. The final contig sequences were then run through the consensus polisher program, Quiver (PacBio), resulting in 3,516 base changes and 624 base insertions or deletions. The BC7 assembly was initially in 7 scaffolds and 785 contigs. Since additional sequencing was not pursued for this genome, a reference-guided gap closure pipeline was employed to resolve hundreds of gaps found throughout the assembly. The gap sequences were predicted from the closed-genome reference (J2315) and used to recruit and locally assemble reads into the gaps to merge the adjacent contigs. The resulting assembly is 296 contigs in 7 scaffolds. As in J2315, each genome has 3 chromosomes and 1 plasmid (6). The chromosomes in BC7 and K56-2 have very similar sizes to those reported in J2315 (3.83 Mb, 3.19 Mb, and 0.88 Mb), except for chromosome 1 in K56-2, which has an estimated size of 3.67 Mb, due to the absence of the large duplication in J2315. The presence of the plasmid was previously detected in K56-2, BC7, and J2315 (8). Sequence data confirm the presence of the plasmid in BC7 and K56-2, with practically no differences between the three strains except for the presence of an additional copy of an insertion element in the J2315 plasmid, pBCJ2315 (6). The genomes were annotated using the annotation pipeline of the J. Craig Venter Institute (JCVI) (http://www.jcvi.org) and submitted to GenBank. Sequence data indicate that K56-2 and BC7 have similar gene contents to that of J2315, with 7,714 and 7,930 open reading frames (ORFs), respectively.

Nucleotide sequence accession numbers.

The B. cenocepacia BC7 whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. ALIZ00000000. The version described in this paper is the second version, ALIZ01000000. The B. cenocepacia K56-2 whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. ALJA00000000. The version described in this paper is the second version, ALJA01000000.
  8 in total

1.  Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis.

Authors:  J J LiPuma; T Spilker; L H Gill; P W Campbell; L Liu; E Mahenthiralingam
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

2.  Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia.

Authors:  Amanda S Engledow; Enrique G Medrano; Eshwar Mahenthiralingam; John J LiPuma; Carlos F Gonzalez
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

3.  Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.

Authors:  P Darling; M Chan; A D Cox; P A Sokol
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

Review 4.  The multifarious, multireplicon Burkholderia cepacia complex.

Authors:  Eshwar Mahenthiralingam; Teresa A Urban; Joanna B Goldberg
Journal:  Nat Rev Microbiol       Date:  2005-02       Impact factor: 60.633

5.  Subspecific differentiation of Burkholderia cepacia isolates in cystic fibrosis.

Authors:  M A Livesley; I A Baxter; P A Lambert; J R Govan; P H Weller; D E Lacey; D G Allison; B Giwercman; N Hoiby
Journal:  J Med Microbiol       Date:  1998-11       Impact factor: 2.472

6.  Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.

Authors:  U S Sajjan; M Corey; M A Karmali; J F Forstner
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

7.  The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.

Authors:  Matthew T G Holden; Helena M B Seth-Smith; Lisa C Crossman; Mohammed Sebaihia; Stephen D Bentley; Ana M Cerdeño-Tárraga; Nicholas R Thomson; Nathalie Bason; Michael A Quail; Sarah Sharp; Inna Cherevach; Carol Churcher; Ian Goodhead; Heidi Hauser; Nancy Holroyd; Karen Mungall; Paul Scott; Danielle Walker; Brian White; Helen Rose; Pernille Iversen; Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho; Adam Baldwin; Christopher Dowson; Bart G Barrell; John R Govan; Peter Vandamme; C Anthony Hart; Eshwar Mahenthiralingam; Julian Parkhill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

8.  Aggressive assembly of pyrosequencing reads with mates.

Authors:  Jason R Miller; Arthur L Delcher; Sergey Koren; Eli Venter; Brian P Walenz; Anushka Brownley; Justin Johnson; Kelvin Li; Clark Mobarry; Granger Sutton
Journal:  Bioinformatics       Date:  2008-10-24       Impact factor: 6.937

  8 in total
  19 in total

1.  The Essential Genome of Burkholderia cenocepacia H111.

Authors:  Steven Higgins; Maria Sanchez-Contreras; Stefano Gualdi; Marta Pinto-Carbó; Aurélien Carlier; Leo Eberl
Journal:  J Bacteriol       Date:  2017-10-17       Impact factor: 3.490

2.  Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia.

Authors:  April S Gislason; Matthew Choy; Ruhi A M Bloodworth; Wubin Qu; Maria S Stietz; Xuan Li; Chenggang Zhang; Silvia T Cardona
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

3.  Burkholderia ubonensis High-Level Tetracycline Resistance Is Due to Efflux Pump Synergy Involving a Novel TetA(64) Resistance Determinant.

Authors:  Nawarat Somprasong; Carina M Hall; Jessica R Webb; Jason W Sahl; David M Wagner; Paul Keim; Bart J Currie; Herbert P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

4.  The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.

Authors:  Steve P Bernier; Susie Son; Michael G Surette
Journal:  J Bacteriol       Date:  2018-08-24       Impact factor: 3.490

5.  Single amino acid substitution in homogentisate 1,2-dioxygenase is responsible for pigmentation in a subset of Burkholderia cepacia complex isolates.

Authors:  Laura A Gonyar; Sarah C Fankhauser; Joanna B Goldberg
Journal:  Environ Microbiol Rep       Date:  2014-12-17       Impact factor: 3.541

6.  In-Frame and Unmarked Gene Deletions in Burkholderia cenocepacia via an Allelic Exchange System Compatible with Gateway Technology.

Authors:  Mustafa Fazli; Joe J Harrison; Michela Gambino; Michael Givskov; Tim Tolker-Nielsen
Journal:  Appl Environ Microbiol       Date:  2015-03-20       Impact factor: 4.792

7.  The Depletion Mechanism Actuates Bacterial Aggregation by Exopolysaccharides and Determines Species Distribution & Composition in Bacterial Aggregates.

Authors:  Patrick R Secor; Lia A Michaels; DeAnna C Bublitz; Laura K Jennings; Pradeep K Singh
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

8.  Tyrosine Phosphorylation and Dephosphorylation in Burkholderia cenocepacia Affect Biofilm Formation, Growth under Nutritional Deprivation, and Pathogenicity.

Authors:  Angel Andrade; Faviola Tavares-Carreón; Maryam Khodai-Kalaki; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2015-11-20       Impact factor: 4.792

9.  Comparative metabolic systems analysis of pathogenic Burkholderia.

Authors:  Jennifer A Bartell; Phillip Yen; John J Varga; Joanna B Goldberg; Jason A Papin
Journal:  J Bacteriol       Date:  2013-10-25       Impact factor: 3.490

10.  Conservation of Resistance-Nodulation-Cell Division Efflux Pump-Mediated Antibiotic Resistance in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Species.

Authors:  Nawarat Somprasong; Jinhee Yi; Carina M Hall; Jessica R Webb; Jason W Sahl; David M Wagner; Paul Keim; Bart J Currie; Herbert P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.